Normal view MARC view ISBD view

Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. [electronic resource]

By:

Basaranoglu, Metin

Contributor(s):

Producer: 20160316Description: 376-84 p. digitalISSN:

1948-5182

Online resources:

Available from publisher's website

In: World journal of hepatology vol. 8

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.
by Rossing, P
2 [Importance of the system hyaluronic acid-hyaluronidase in rheumatic joint diseases].
by ROSSING, P
3 [Clinical studies with 1-phenylpropanol as a choleretic].
by ROSSING, P
4 [Experience in and requirements of medical and nursing care in a modern hospital].
by ROSSING, P
5 Doubling of serum creatinine: is it sensitive and relevant?
by Rossing, P
6 The changing epidemiology of diabetic microangiopathy in type 1 diabetes.
by Rossing, P
7 Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.
by Rossing, P
8 [Studies on the cardiovascular effect of noradrenalin in man].
by ROSSING, P
9 [Risk factors in the progression of diabetic nephropathies].
by Rossing, P
10 Promotion, prediction, and prevention of progression in diabetic nephropathy.
by Rossing, P
11 [The critique of hyaluronidase theories in rheumatic diseases].
by ROSSING, P
12 [The enzyme hyaluronidase, its biological, pathogenetic, and clinical significance].
by ROSSING, P
13 [The treatment of coronary and peripheral blood circulation disorders with noradrenalin].
by ROSSING, P
14 Hyaluronidase therapy of inflammatory and degenerative joint diseases.
by ROSSING, P
15 [Honeycomb lung with diffuse myomatosis diagnosed as recurrent chylothorax].
by BRANDT, M
16 [Fungus enzymes and succus liquiritiae (lacrulcillin) in the treatment of intestinal diseases].
by ROSSING, P
17 Calcium antagonists and the diabetic hypertensive patient.
by Parving, H H
18 Diabetes and risk of adverse events with calcium antagonists.
by Parving, H H
19 Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
by Parving, H H
20 The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.
by Parving, H H